FDA Approves UCLA’s Heart Tissue Regeneration Drug AD-NP1 for Clinical Trials
In a groundbreaking advancement that could redefine the treatment of organ injury, UCLA cardiologists have unveiled a novel therapeutic approach ...
Tag: Monoclonal antibody drug development
POPULAR NEWS
-
Patients as co-researchers: what two German projects reveal about meaningful involvement in oncology and palliative care research
-
Peptide-Functionalized Biomaterials Could Boost CAR-NK Cell Therapy Against Solid Tumors
-
Nanoimprint Lithography Produces High-Efficiency Mid-Infrared Gratings for Pulse Compression
-
Machine learning model predicts tensile strength of fiber-reinforced polymer composites